Expertise in
15
conditions

Dr. Donald F. Gardner

Endocrinology
Memorial Endocrinology And Diabetes
1140 Business Center Dr Ste 550, 
Houston, TX 
Accepting New Patients
Offers Telehealth
Referral required
Before you request
Expertise in
15
conditions
Memorial Endocrinology And Diabetes
1140 Business Center Dr Ste 550, 
Houston, TX 

Overview

Donald Gardner is an Endocrinologist practicing medicine in Houston, Texas.

Dr. Gardner is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Hypothyroidism, Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), and Obesity in Children.

He is actively involved in clinical research, participating in 6 clinical trials. Dr. Gardner is currently accepting new patients.

Specialties

Endocrinology

Licenses

Specialist in TX

Hospital Affiliations

Memorial Hermann Memorial City Hospital
Memorial Hermann Katy Hospital
Houston Methodist West Hospital
Memorial Hermann - Texas Medical Center
Columbus Community Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Community Health
  • EPO
  • HMO
Community Health Choice
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
EMI Health
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 20 Less Insurance Carriers -

Locations

Memorial Endocrinology and Diabetes
1140 Business Center Dr Ste 550, Houston, TX 77043

Additional Areas of Focus

Dr. Gardner has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Hypoparathyroidism
Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase 3, Multicenter, Randomized, Parallel-Design, Open-Label Trial to Evaluate the Efficacy and Safety of LY3209590 Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin (QWINT-3)
A Phase 3, Multicenter, Randomized, Parallel-Design, Open-Label Trial to Evaluate the Efficacy and Safety of LY3209590 Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin (QWINT-3)
Enrollment Status: Completed
Publish Date: June 03, 2025
Intervention Type: Drug
Study Drugs: LY3209590, Insulin Degludec
Study Phase: Phase 3
A Phase 3, Parallel-Design, Open-Label, Randomized Control Study to Evaluate the Efficacy and Safety of LY3209590 as a Weekly Basal Insulin Compared to Insulin Degludec in Insulin Naïve Adults With Type 2 Diabetes
A Phase 3, Parallel-Design, Open-Label, Randomized Control Study to Evaluate the Efficacy and Safety of LY3209590 as a Weekly Basal Insulin Compared to Insulin Degludec in Insulin Naïve Adults With Type 2 Diabetes
Enrollment Status: Completed
Publish Date: May 16, 2025
Intervention Type: Drug
Study Phase: Phase 3
Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo for Maintenance of Weight Loss in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight-Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-4)
Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo for Maintenance of Weight Loss in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight-Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-4)
Enrollment Status: Completed
Publish Date: May 22, 2024
Intervention Type: Other, Drug
Study Drug: Tirzepatide
Study Phase: Phase 3
A Randomized, Phase 3, Open-label Trial Comparing the Effect of the Addition of Tirzepatide Once Weekly Versus Insulin Lispro (U100) Three Times Daily in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin (SURPASS-6)
A Randomized, Phase 3, Open-label Trial Comparing the Effect of the Addition of Tirzepatide Once Weekly Versus Insulin Lispro (U100) Three Times Daily in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin (SURPASS-6)
Enrollment Status: Completed
Publish Date: November 02, 2023
Intervention Type: Drug
Study Drugs: Tirzepatide, Insulin Lispro, Insulin Glargine
Study Phase: Phase 3
A Study of LY900014 in Participants With Type 2 Diabetes Using Continuous Glucose Monitoring
A Study of LY900014 in Participants With Type 2 Diabetes Using Continuous Glucose Monitoring
Enrollment Status: Completed
Publish Date: March 03, 2023
Intervention Type: Drug
Study Drugs: LY900014, Insulin Glargine
Study Phase: Phase 3
A Phase 3, Randomized, Open-Label Trial Comparing Efficacy and Safety of Tirzepatide Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Patients With Type 2 Diabetes
A Phase 3, Randomized, Open-Label Trial Comparing Efficacy and Safety of Tirzepatide Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Patients With Type 2 Diabetes
Enrollment Status: Completed
Publish Date: February 14, 2022
Intervention Type: Drug
Study Drugs: Tirzepatide, Semaglutide
Study Phase: Phase 3
View 5 Less Clinical Trials
Similar Doctors
Expertise in
31
conditions
Expertise in
31
conditions
Referral required
Before you request

Office

1515 Holcombe Blvd Unit 1461, 
Houston, TX 
 (13.1 miles away)
713-792-6610
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Steven Waguespack is an Endocrinologist practicing medicine in Houston, Texas. Dr. Waguespack is highly rated in 31 conditions, according to our data. His clinical expertise encompasses Thyroid Cancer, Medullary Thyroid Carcinoma, Multiple Endocrine Neoplasia, Thyroidectomy, and Parathyroidectomy. Dr. Waguespack is currently accepting new patients.

Expertise in
22
conditions
Dr. Mimi I. Hu
Endocrinology
Expertise in
22
conditions
Dr. Mimi I. Hu
Endocrinology
Referral required
Before you request

UT MD Anderson Cancer Center

1515 Holcombe Blvd, 
Houston, TX 
 (13.3 miles away)
281-566-1900
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Mimi Hu is an Endocrinologist practicing medicine in Houston, Texas. Dr. Hu is highly rated in 22 conditions, according to our data. Her clinical expertise encompasses Medullary Thyroid Carcinoma, Thyroid Cancer, Milk-Alkali Syndrome, Thyroidectomy, and Tissue Biopsy. Dr. Hu is currently accepting new patients.

Expertise in
19
conditions
Dr. Naifa L. Busaidy
Endocrinology
Expertise in
19
conditions
Dr. Naifa L. Busaidy
Endocrinology
Referral required
Before you request

UT MD Anderson Cancer Center

1515 Holcombe Blvd, 
Houston, TX 
 (13.3 miles away)
713-563-7600
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Naifa Busaidy is an Endocrinologist practicing medicine in Houston, Texas. Dr. Busaidy is highly rated in 19 conditions, according to our data. Her clinical expertise encompasses Thyroid Cancer, Anaplastic Thyroid Cancer, Medullary Thyroid Carcinoma, Thyroidectomy, and Parathyroidectomy. Dr. Busaidy is currently accepting new patients.

Frequently Asked Questions about Dr. Donald F. Gardner

How do I make an appointment with Dr. Donald F. Gardner?

You can book an appointment with Dr. Donald F. Gardner by calling their office at 713-984-8200. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Donald F. Gardner a top-rated expert for Hypothyroidism?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Donald F. Gardner is classified as an Distinguished expert for Hypothyroidism, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Donald F. Gardner specialize in?

While Dr. Donald F. Gardner is a Endocrinology, they have specific expertise in Hypothyroidism, Type 1 Diabetes (T1D), and Type 2 Diabetes (T2D). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Endocrinology.

Does Dr. Donald F. Gardner accept my insurance?

Dr. Donald F. Gardner accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 713-984-8200 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Gardner's expertise for a condition
ConditionClose
    View All 13 Advanced Conditions
    View All 22 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile